JP2994956B2 - Low-substituted hydroxypropylcellulose, composition thereof and tablet thereof - Google Patents

Low-substituted hydroxypropylcellulose, composition thereof and tablet thereof

Info

Publication number
JP2994956B2
JP2994956B2 JP6117854A JP11785494A JP2994956B2 JP 2994956 B2 JP2994956 B2 JP 2994956B2 JP 6117854 A JP6117854 A JP 6117854A JP 11785494 A JP11785494 A JP 11785494A JP 2994956 B2 JP2994956 B2 JP 2994956B2
Authority
JP
Japan
Prior art keywords
low
weight
tablet
substituted hydroxypropylcellulose
tableting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP6117854A
Other languages
Japanese (ja)
Other versions
JPH07324101A (en
Inventor
光男 成田
宏恭 小久保
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shin Etsu Chemical Co Ltd
Original Assignee
Shin Etsu Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Etsu Chemical Co Ltd filed Critical Shin Etsu Chemical Co Ltd
Priority to JP6117854A priority Critical patent/JP2994956B2/en
Publication of JPH07324101A publication Critical patent/JPH07324101A/en
Application granted granted Critical
Publication of JP2994956B2 publication Critical patent/JP2994956B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、医薬品等の錠剤に結合
剤として添加されている低置換度ヒドロキシプロピルセ
ルロースが配合されている組成物およびその低置換度ヒ
ドロキシプロピルセルロースで結合されている錠剤に関
するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition containing a low-substituted hydroxypropylcellulose, which is added to a tablet such as a pharmaceutical product as a binder, and a tablet bound with the low-substituted hydroxypropylcellulose. It is about.

【0002】[0002]

【従来の技術】医薬品等の錠剤は、錠剤中に含まれてい
る結合剤の膨潤によって崩壊する。錠剤の結合剤には、
例えば低置換度ヒドロキシプロピルセルロース、カルボ
キシルメチルセルロースおよびそのカルシウム塩、デン
プンおよびその誘導体が挙げられる。この中で低置換度
ヒドロキシプロピルセルロースは薬物との相互作用が少
ない非イオン性の結合剤である。低置換度ヒドロキシプ
ロピルセルロースが結合剤として使用されていること
は、特公昭46-42792号公報、特公昭57-53100号公報に記
載されている。
2. Description of the Related Art Tablets such as pharmaceuticals disintegrate due to swelling of a binder contained in the tablet. Tablet binders include:
Examples thereof include low-substituted hydroxypropylcellulose, carboxymethylcellulose and its calcium salt, starch and its derivatives. Among them, low-substituted hydroxypropylcellulose is a nonionic binder having little interaction with a drug. The use of low-substituted hydroxypropylcellulose as a binder is described in JP-B-46-42792 and JP-B-57-53100.

【0003】近年、錠剤は服用しやすいように小型化さ
れ、結合剤等の添加が抑えられる傾向にある。このため
結合剤には、少ない添加量で錠剤の崩壊性を高めるもの
が望まれている。また、主薬成分が錠剤中に均一に分散
されかつ、錠剤の重量偏差が小さくなるには、結合剤は
流動性が優れていることが必要である。
[0003] In recent years, tablets have been reduced in size so that they can be easily taken, and the addition of binders and the like tends to be suppressed. For this reason, a binder that enhances the disintegration of tablets with a small amount of addition is desired. Further, in order for the main ingredient to be uniformly dispersed in the tablet and to reduce the weight deviation of the tablet, the binder must have excellent fluidity.

【0004】錠剤を製造するには、主薬成分と各種添加
剤とを配合して錠剤用組成物を調製し、この組成物から
錠剤を製錠する。製錠方法には、組成物を直接打錠する
方法および組成物を造粒してから打錠する方法がある。
製錠に先立って組成物を造粒する場合、操作が容易なこ
とから微粉を混ぜた組成物を流動させて造粒品を造る流
動層造粒が行なわれる。流動層造粒の際、多量の低置換
度ヒドロキシプロピルセルロースが添加されている組成
物を造粒すると、密度が低く嵩高い造粒品が得られるこ
とがある。嵩高い造粒品を打錠すると、打錠速度を大き
くしたとき、錠剤の重量が制限される。
[0004] In the production of tablets, a base composition and various additives are blended to prepare a tablet composition, and tablets are formed from the composition. Tableting methods include a method in which the composition is directly compressed and a method in which the composition is granulated and then compressed.
When the composition is granulated prior to tableting, fluidized-bed granulation is performed in which the composition mixed with fine powder is fluidized to form a granulated product because of easy operation. In the case of fluidized bed granulation, if a composition to which a large amount of low-substituted hydroxypropylcellulose is added is granulated, a granulated product having a low density and a high bulk may be obtained. When tableting bulky granules, the tablet weight is limited when the tableting speed is increased.

【0005】[0005]

【発明が解決しようとする課題】本発明は前記の課題を
解決するためなされたもので、少ない添加量でも錠剤に
優れた崩壊性および結合性を付与し、また添加量が多い
場合でも密度が高い造粒品を製造させることができる低
置換度ヒドロキシプロピルセルロースが配合されている
組成物およびその低置換度ヒドロキシプロピルセルロー
スで結合されている錠剤を提供することを目的とする。
DISCLOSURE OF THE INVENTION The present invention has been made to solve the above-mentioned problems, and provides a tablet with excellent disintegration and binding properties even with a small amount of addition, and has a high density even when the amount of addition is large. It is an object of the present invention to provide a composition containing a low-substituted hydroxypropylcellulose that can produce a high-granulated product, and a tablet combined with the low-substituted hydroxypropylcellulose.

【0006】[0006]

【課題を解決するための手段】前記の目的を達成するた
めになされた本発明の低置換度ヒドロキシプロピルセル
ロースは安息角が45°未満を示し、活性アルミナ80
重量部に対して20重量部が配合され成形圧1トンで直
径15mmの円板に成形されたものが水を吸収して膨潤
率する際の体積増加率が100%以上を示す。
The low-substituted hydroxypropylcellulose of the present invention, which has been made to achieve the above object, has an angle of repose of less than 45 ° and activated alumina 80%.
20 parts by weight with respect to the parts by weight are mixed and molded into a disk having a diameter of 15 mm at a molding pressure of 1 ton. The volume increase rate when absorbing water and swelling rate is 100% or more.

【0007】安息角の測定方法は以下の通りである。ヒ
ドロキシプロピルセルロースの粉体を直径80mmの円
板状の台の上に75mmの高さより流下させる。堆積し
ている粉体と台との接触角を測定する。流動性がよい粉
体は、大きく広がるので安息角が小さくなる。流動性が
悪い粉体は堆積してしまうので安息角が大きくなる。安
息角が45°未満の場合、重量偏差が小さく硬度が高い
錠剤が得られる。45°以上では直接打錠法で製錠する
場合、配合成分の流動性が悪く、製錠される錠剤の重量
変動が大きくなる。流動層造粒の場合には、造粒末のか
さ密度が低くなる。
The method of measuring the angle of repose is as follows. The hydroxypropylcellulose powder is allowed to flow down from a height of 75 mm onto a disk-shaped table having a diameter of 80 mm. The contact angle between the deposited powder and the table is measured. A powder having good fluidity spreads greatly, and therefore has a small angle of repose. The powder having poor fluidity accumulates, so that the angle of repose increases. When the angle of repose is less than 45 °, a tablet having a small weight deviation and a high hardness can be obtained. When the temperature is 45 ° or more, when tableting is performed by the direct tableting method, the fluidity of the components is poor, and the weight fluctuation of the tablet to be tableted is large. In the case of fluidized bed granulation, the bulk density of the granulated powder is low.

【0008】膨潤率は低置換度ヒドロキシプロピルセル
ロースが水を吸収し、膨潤したときの体積の増加率であ
る。活性アルミナ80重量部に対して20重量部が配合
され成形圧1トンで直径15mmの円板に成形されたと
きの膨潤率が100%以上となる低置換度ヒドロキシプ
ロピルセルロースは、わずかの添加で錠剤に優れた崩壊
性を付与する。膨潤率が100%以下の低置換度ヒドロ
キシプロピルセルロースは、多量の添加でないと錠剤を
崩壊させることができない。市販の低置換度ヒドロキシ
プロピルセルロースは、膨潤率が100%以下なので、
多量の添加を必要とする。
[0008] The swelling ratio is the rate of increase in volume when the low-substituted hydroxypropylcellulose absorbs water and swells. Low-substituted hydroxypropylcellulose, which is 20 parts by weight based on 80 parts by weight of activated alumina and has a swelling ratio of 100% or more when molded into a disk having a diameter of 15 mm at a molding pressure of 1 ton, is added with a small amount. Provides excellent disintegration to tablets. The low-substituted hydroxypropylcellulose having a swelling ratio of 100% or less cannot disintegrate tablets unless added in a large amount. Since commercially available low-substituted hydroxypropylcellulose has a swelling ratio of 100% or less,
Requires a large amount of addition.

【0009】低置換度ヒドロキシプロピルセルロースの
製造方法は以下の通りである。水酸化アルカリを触媒と
し、セルロースにプロピレンオキサイドを置換反応させ
る。次に、触媒として用いたアルカリの存在下あるいは
必要に応じてアルカリを追加し、水を加えて混合し、生
成物の全部あるいは一部を溶解して繊維質を減少させ
る。この溶液を酢酸、塩酸等の酸で中和した後、精製、
乾燥、粉砕の工程を経てヒドロキシプロピルセルロース
が得られる。繊維質の減少によってヒドロキシプロピル
セルロースの粒子が球状になり、膨潤率が100%以
上、かつ安息角が45°未満のヒドロキシプロピルセル
ロースが生成される。
The method for producing low-substituted hydroxypropylcellulose is as follows. The substitution reaction of propylene oxide with cellulose is carried out using alkali hydroxide as a catalyst. Next, an alkali is added in the presence of the alkali used as a catalyst or if necessary, water is added and mixed, and all or a part of the product is dissolved to reduce the fiber quality. After neutralizing this solution with an acid such as acetic acid or hydrochloric acid, purification,
Hydroxypropylcellulose is obtained through the steps of drying and pulverization. Hydroxypropylcellulose particles become spherical due to the decrease in fiber, and hydroxypropylcellulose having a swelling ratio of 100% or more and an angle of repose of less than 45 ° is produced.

【0010】低置換度ヒドロキシプロピルセルロースの
ヒドロキシプロポキシル基含有量は5〜16重量%、特
に7〜13重量%の範囲が望ましい。含有量が5重量%
以下の場合、ヒドロキシプロピルセルロースの膨潤率が
低くなり、錠剤の崩壊性が不十分となる。含有量が16
重量%以上の場合には、ヒドロキシプロピルセルロース
が最後には水溶性となってしまう。平均粒子径は5〜1
50μmが好ましく、特に40〜100μmの範囲が望
ましい。5μm以下では、ヒドロキシプロピルセルロー
スの流動性が悪くなり、流動層造粒が行ないにくくな
る。150μm以上では、ヒドロキシプロピルセルロー
スと薬物との混合が不均一となり結合性が低下する。こ
のため造粒末のかさ密度が低くなり、錠剤の硬度が低く
なる。
The hydroxypropoxyl group content of the low-substituted hydroxypropylcellulose is preferably in the range of 5 to 16% by weight, particularly 7 to 13% by weight. Content is 5% by weight
In the following cases, the swelling ratio of hydroxypropylcellulose becomes low, and the disintegration of the tablet becomes insufficient. 16 content
If it is greater than or equal to weight percent, the hydroxypropyl cellulose will eventually become water-soluble. Average particle size is 5-1
It is preferably 50 μm, and particularly preferably in the range of 40 to 100 μm. If it is less than 5 μm, the fluidity of hydroxypropylcellulose will be poor, making it difficult to perform fluidized bed granulation. If it is 150 μm or more, the mixing of hydroxypropylcellulose and the drug is not uniform, and the binding property is reduced. For this reason, the bulk density of the granulated powder decreases, and the hardness of the tablet decreases.

【0011】低置換度ヒドロキシプロピルセルロース組
成物は前記の低置換度ヒドロキシプロピルセルロースを
成分に含んでおり、他の成分として、例えば賦形剤、結
合剤、潤沢剤、着色剤等を含んでいる。
The low-substituted hydroxypropylcellulose composition contains the above-mentioned low-substituted hydroxypropylcellulose as a component, and other components such as an excipient, a binder, a lubricant, and a colorant. .

【0012】錠剤は、前記の低置換度ヒドロキシプロピ
ルセルロースで結合されており、低置換度ヒドロキシプ
ロピルセルロース組成物を直接打錠するか、流動層造粒
を経て打錠して得られる。直接打錠の場合、低置換度ヒ
ドロキシプロピルセルロースを2%以上配合し、流動層
造粒の場合、5%以上配合する。
The tablet is bound by the above-mentioned low-substituted hydroxypropylcellulose, and is obtained by directly tableting the low-substituted hydroxypropylcellulose composition or by tableting through fluid bed granulation. In the case of direct compression, 2% or more of low-substituted hydroxypropylcellulose is blended, and in the case of fluidized-bed granulation, 5% or more is blended.

【0013】[0013]

【作用】本発明の低置換度ヒドロキシプロピルセルロー
スは、市販のヒドロキシプロピルセルロースと比較して
繊維状の粒子が少なく粒子形状が球状に近い。ヒドロキ
シプロピルセルロースが水を吸収し膨潤するときには、
粒子内部に圧力が発生する。繊維状の粒子では膨潤する
ときの圧力が錠剤の空隙に吸収されてしまうが、球状の
粒子では圧力が全体に伝播される。このため錠剤中のヒ
ドロキシプロピルセルロースの膨潤が大きくなり、錠剤
の崩壊性が高くなる。
The low-substituted hydroxypropylcellulose of the present invention has fewer fibrous particles than the commercially available hydroxypropylcellulose, and the particle shape is nearly spherical. When hydroxypropylcellulose absorbs water and swells,
Pressure is generated inside the particles. In the case of fibrous particles, the pressure at the time of swelling is absorbed by the pores of the tablet, whereas in the case of spherical particles, the pressure is transmitted throughout. For this reason, the swelling of hydroxypropylcellulose in the tablet increases, and the disintegration of the tablet increases.

【0014】安息角は、流動層造粒を経て得られる造粒
末のかさ密度に大きな影響を与える。安息角が45°未
満の低置換度ヒドロキシプロピルセルロースは流動性が
優れており、流動層造粒で得られる造粒末のかさ密度が
高くなる。かさ密度の高い造粒末を打錠することで、打
錠速度が大きい場合でも錠剤の重量を維持できる。
The angle of repose greatly affects the bulk density of the granulated powder obtained through fluidized bed granulation. Low-substituted hydroxypropylcellulose having an angle of repose of less than 45 ° has excellent fluidity, and the bulk density of the granulated powder obtained by fluidized bed granulation becomes high. By tableting granulated powder having a high bulk density, the weight of the tablet can be maintained even when the tableting speed is high.

【0015】[0015]

【発明の効果】本発明の低置換度ヒドロキシプロピルセ
ルロースは直接打錠用組成物にわずかに配合されるだけ
で、錠剤に優れた崩壊性を付与する。錠剤に含まれてい
たヒドロキシプロピルセルロースの割合が減少するた
め、錠剤は小型化され、服用しやすくなる。また、流動
層造粒用組成物中に多量に添加する場合でも、かさ密度
が高い造粒品を製造できる。
Industrial Applicability The low-substituted hydroxypropylcellulose of the present invention imparts excellent disintegration to tablets by being slightly added to a composition for direct compression. Since the proportion of hydroxypropylcellulose contained in the tablet is reduced, the tablet is reduced in size and becomes easier to take. Even when a large amount is added to the fluidized bed granulation composition, a granulated product having a high bulk density can be produced.

【0016】[0016]

【実施例】以下、本発明の実施例を詳細に説明する。Embodiments of the present invention will be described below in detail.

【0017】実施例1 低置換度ヒドロキシプロピルセルロースの合成 ウッドパルプを、49重量%の苛性ソーダ(NaOH)
に浸漬後、圧搾してNaOH24.6重量%、セルロー
ス48.2重量%、水27.2重量%の組成のアルカリ
セルロースを得た。このアルカリセルロース100gを
反応器に仕込み、窒素置換を行なった。窒素置換後、プ
ロピレンオキサイド10.7gを反応器へ仕込み、撹拌
しながら40℃で1時間、および70℃で1時間反応さ
せてヒドロキシプロピルセルロースを得た。ニーダーに
温水265gを入れ、温水にヒドロキシプロピルセルロ
ースを分散させ、温度45℃で30分間混練した。その
後、33重量%酢酸水溶液112gを添加してヒドロキ
シプロピルセルロースを析出させた。析出したヒドロキ
シプロピルセルロースを約80℃の熱水で洗浄した後、
脱水、乾燥し高速回転衝撃粉砕機で粉砕した。目開き7
5μmのふるいでこの粉末から粗大粉末を除去し、ヒド
ロキシプロポキシル基含有率が11.0%の微粉末を得
た。この微粉末を試料No.1とした。
Example 1 Synthesis of Low-Substituted Hydroxypropylcellulose Wood pulp was prepared by adding 49% by weight of caustic soda (NaOH).
After being immersed in water, compression was performed to obtain alkali cellulose having a composition of 24.6% by weight of NaOH, 48.2% by weight of cellulose, and 27.2% by weight of water. 100 g of this alkali cellulose was charged into a reactor, and the atmosphere was replaced with nitrogen. After the replacement with nitrogen, 10.7 g of propylene oxide was charged into the reactor and reacted with stirring at 40 ° C. for 1 hour and at 70 ° C. for 1 hour to obtain hydroxypropylcellulose. 265 g of warm water was put into a kneader, hydroxypropyl cellulose was dispersed in the warm water, and kneaded at a temperature of 45 ° C. for 30 minutes. Thereafter, 112 g of a 33% by weight acetic acid aqueous solution was added to precipitate hydroxypropylcellulose. After washing the precipitated hydroxypropylcellulose with hot water of about 80 ° C,
Dewatered, dried and pulverized with a high-speed rotary impact pulverizer. Aperture 7
The coarse powder was removed from the powder with a 5 μm sieve to obtain a fine powder having a hydroxypropoxyl group content of 11.0%. This fine powder was used as sample No. It was set to 1.

【0018】低置換度ヒドロキシプロピルセルロースの
物性 試料No.1の安息角をパウダーテスターRT−D型
(細川粉体工学研究所製)による円錐堆積法で測定し
た。測定は以下の通りである。粉体をパウダーテスター
の台上に流下し、堆積した粉体と台との隣線に分度器を
合わせ、粉体と台との接触角を測定し、その結果を表1
に示した。次いで、試料No.1の平均粒子形、かさ密
度を測定し、その結果を表1に示した。
Physical Properties of Low-Substituted Hydroxypropylcellulose Sample No. The angle of repose of No. 1 was measured by a cone deposition method using a powder tester RT-D type (manufactured by Hosokawa Powder Engineering Laboratory). The measurement is as follows. The powder was allowed to flow down onto the powder tester table, a protractor was set on the line adjacent to the deposited powder and the table, and the contact angle between the powder and the table was measured.
It was shown to. Then, the sample No. The average particle shape and bulk density of Sample No. 1 were measured, and the results are shown in Table 1.

【0019】10gの試料No.1と、40gの活性ア
ルミナ(200メッシュ)とをV型混練器で混合した
後、その混合物500mgを成形圧1トンで直径15m
mの錠剤に圧縮成形した。錠剤に水を吸収させ体積の増
加率を測定し、膨潤率を算出した。図1にその測定結果
を示す。
For 10 g of sample No. 1 and 40 g of activated alumina (200 mesh) were mixed in a V-type kneader, and 500 mg of the mixture was subjected to a molding pressure of 1 ton and a diameter of 15 m.
m tablets. Water was absorbed into the tablets, the rate of increase in volume was measured, and the swelling rate was calculated. FIG. 1 shows the measurement results.

【0020】直接打錠による製錠 アスピリン造粒末(アスピリン/コーンスターチ=95
/5)を基剤として、試料No.1が10重量部、アス
ピリン造粒末が90重量部、ステアリン酸マグネシウム
が0.5重量部という配合比で直接打錠用組成物を調製
した。
Tableting by direct compression Aspirin granulated powder (aspirin / corn starch = 95)
/ 5) as a base, sample No. 1 was 10 parts by weight, aspirin granulated powder was 90 parts by weight, and magnesium stearate was 0.5 parts by weight to prepare a composition for direct compression.

【0021】RT−S15K−T35(菊水製作所製)
により回転数30rpm、打錠圧0.6トンでこの直接
打錠用組成物を打錠し、直径が9mm、重量が300m
gの錠剤を得た。この錠剤の重量偏差、硬度、崩壊時間
を測定し、その結果を表1に示す。
RT-S15K-T35 (manufactured by Kikusui Seisakusho)
The composition for direct compression was tableted at a rotation speed of 30 rpm and a tableting pressure of 0.6 ton, with a diameter of 9 mm and a weight of 300 m.
g tablets were obtained. The weight deviation, hardness, and disintegration time of this tablet were measured, and the results are shown in Table 1.

【0022】流動層造粒 100gの試料No.1に、アセトアミノフェン(微
粉)160g、乳糖98g、コーンスターチ42gを配
合して流動層造粒用組成物を調製した。AEROMAT
IC STREA−1型(富士産業製)により吸気温度
が70℃、HPC−LEP(信越化学工業製)の5重量
%水溶液をスプレー速度20g/分で流動層造粒用組成
物に噴射し、流動層造粒を行なった。得られた造粒末を
目開き1400μmのふるいで不純物を除去した後、平
均粒子径、かさ密度を測定し、その結果を表1に示し
た。
Fluid bed granulation Sample No. 100 g 1 was mixed with 160 g of acetaminophen (fine powder), 98 g of lactose, and 42 g of corn starch to prepare a composition for fluidized bed granulation. AEROMAT
A 5% by weight aqueous solution of HPC-LEP (manufactured by Shin-Etsu Chemical Co., Ltd.) is sprayed onto the fluidized-bed granulating composition at a spray rate of 20 g / min with an IC STREA-1 type (manufactured by Fuji Sangyo) at an intake temperature of 70 ° C. Layer granulation was performed. After removing the obtained granulated powder with a sieve having a mesh size of 1400 μm, the average particle diameter and the bulk density were measured. The results are shown in Table 1.

【0023】次いで、造粒末100重量部、ステアリン
酸マグネシウム0.5重量部という配合比で打錠末を調
製した。RT−S15K−T35(菊水製作所製)によ
り回転数30rpm、打錠圧1トンで造粒末を打錠し、
直径が8mm、重量が200mgの錠剤を得た。打錠後
の錠剤の硬度、崩壊時間を測定し、その結果を表1に示
した。
Next, a tableting powder was prepared with a mixing ratio of 100 parts by weight of the granulated powder and 0.5 part by weight of magnesium stearate. The granulated powder is tableted with RT-S15K-T35 (manufactured by Kikusui Seisakusho) at a rotation speed of 30 rpm and a tableting pressure of 1 ton.
A tablet having a diameter of 8 mm and a weight of 200 mg was obtained. The hardness and disintegration time of the tablet after tableting were measured, and the results are shown in Table 1.

【0024】回転数30rpm、打錠圧1トンで重量が
200mgの錠剤を打錠した後、回転数のみを45rp
m、50rpmと変化させ、各回転数で打錠した錠剤の
重量を測定し、その結果を表2に示した。
After tableting a tablet weighing 200 mg at a rotation speed of 30 rpm and a tableting pressure of 1 ton, only the rotation speed was increased to 45 rpm.
m and 50 rpm, the weight of the tablets compressed at each rotation speed was measured, and the results are shown in Table 2.

【0025】実施例2 低置換度ヒドロキシプロピルセルロースの合成および物
性 実施例1と同様に、低置換度ヒドロキシプロピルセルロ
ースを合成した。目開きを180μmにして、この粉末
から不純物を除去し、ヒドロキシプロポキシル基含有率
が11.0%の微粉末を得た。この微粉末を試料No.
2とした。実施例1と同様に試料No.2の平均粒子
形、かさ密度および安息角を測定し、その結果を表1に
示した。
Example 2 Synthesis and Physical Properties of Low-Substituted Hydroxypropyl Cellulose In the same manner as in Example 1, low-substituted hydroxypropyl cellulose was synthesized. The opening was set to 180 μm, and impurities were removed from the powder to obtain a fine powder having a hydroxypropoxyl group content of 11.0%. This fine powder was used as sample No.
And 2. As in Example 1, the sample No. The average particle shape, bulk density, and angle of repose of Sample No. 2 were measured, and the results are shown in Table 1.

【0026】実施例1と同様に試料No.2を錠剤に圧
縮成形したときの膨潤率を測定し、その結果を図1に示
した。
In the same manner as in Example 1, the sample No. 2 was compression-molded into a tablet, and the swelling ratio was measured. The result is shown in FIG.

【0027】直接打錠による製錠 低置換度ヒドロキシプロピルセルロースが試料No.2
であることを除いて、実施例1と同様に直接打錠用組成
物を調製して直接打錠を行なった。錠剤の重量偏差、硬
度、崩壊時間を測定し、その結果を表1に示す。
Tableting by direct compression Sample No. 2
A tableting composition was prepared and tableted directly in the same manner as in Example 1 except that The weight deviation, hardness and disintegration time of the tablets were measured, and the results are shown in Table 1.

【0028】流動層造粒 低置換度ヒドロキシプロピルセルロースが試料No.2
であることを除いて、実施例1と同様に、流動層造粒お
よび造粒末の打錠を行なった。重量200gの造粒末の
平均粒子径、かさ密度、および錠剤の硬度、崩壊時間を
測定し、その結果を表1に示す。
Fluid bed granulation The low-substituted hydroxypropylcellulose was obtained from Sample No. 2
In the same manner as in Example 1, fluidized-bed granulation and tableting of the granulated powder were carried out. The average particle size, bulk density, tablet hardness and disintegration time of the granulated powder having a weight of 200 g were measured, and the results are shown in Table 1.

【0029】回転数30rpm、打錠圧1トンで重量が
200mgの錠剤を打錠した後、回転数のみを45rp
m、50rpmと変化させ、各回転数で打錠した錠剤の
重量を測定し、その結果を表2に示した。
After tableting a tablet weighing 200 mg at a rotation speed of 30 rpm and a tableting pressure of 1 ton, only the rotation speed was increased to 45 rpm.
m and 50 rpm, the weight of the tablets compressed at each rotation speed was measured, and the results are shown in Table 2.

【0030】比較例1 低置換度ヒドロキシプロピルセルロースの物性 低置換度ヒドロキシプロピルセルロースを市販品である
LH−11(信越化学工業製)とした。実施例1と同様
にLH−11の平均粒子径、かさ密度および安息角を測
定し、その結果を表1に示した。
Comparative Example 1 Physical Properties of Low-Substituted Hydroxypropyl Cellulose Low-substituted hydroxypropyl cellulose was used as a commercially available product, LH-11 (manufactured by Shin-Etsu Chemical Co., Ltd.). The average particle diameter, bulk density, and angle of repose of LH-11 were measured in the same manner as in Example 1, and the results are shown in Table 1.

【0031】実施例1と同様にLH−11を圧縮成形
し、膨潤率を測定した。その結果を図1に示す。LH−
11の膨潤率は100%以下であった。
LH-11 was compression molded in the same manner as in Example 1, and the swelling ratio was measured. The result is shown in FIG. LH-
The swelling ratio of No. 11 was 100% or less.

【0032】直接打錠による製錠 低置換度ヒドロキシプロピルセルロースがLH−11で
あることを除いて、実施例1と同様に、直接打錠用組成
物を調製し直接打錠を行なった。錠剤の重量偏差、硬
度、崩壊時間を表1に示した。
Tableting by Direct Compression A composition for direct compression was prepared and directly tableted in the same manner as in Example 1 except that the low-substituted hydroxypropylcellulose was LH-11. Table 1 shows the weight deviation, hardness, and disintegration time of the tablets.

【0033】流動層造粒 低置換度ヒドロキシプロピルセルロースがLH−11で
あることを除いて、実施例1と同様に、流動層造粒およ
び造粒末の打錠を行なった。重量200gの造粒末の平
均粒子径、かさ密度、および錠剤の硬度、崩壊時間を測
定し、その結果を表1に示す。
Fluid bed granulation Fluid bed granulation and tableting of the granulated powder were carried out in the same manner as in Example 1 except that the low-substituted hydroxypropylcellulose was LH-11. The average particle size, bulk density, tablet hardness and disintegration time of the granulated powder having a weight of 200 g were measured, and the results are shown in Table 1.

【0034】回転数30rpm、打錠圧1トンで重量が
200mgの錠剤を打錠した後、回転数のみを45rp
m、50rpmと変化させ、各回転数で打錠した錠剤の
重量を測定し、その結果を表2に示した。
After tableting a tablet weighing 200 mg at a rotation speed of 30 rpm and a tableting pressure of 1 ton, only the rotation speed was increased to 45 rpm.
m and 50 rpm, the weight of the tablets compressed at each rotation speed was measured, and the results are shown in Table 2.

【0035】比較例2 低置換度ヒドロキシプロピルセルロースの物性 低置換度ヒドロキシプロピルセルロースを市販品である
LH−21(信越化学工業製)とした。実施例1と同様
にLH−21の平均粒子径、かさ密度および安息角を測
定し、その結果を表1に示した。
Comparative Example 2 Physical Properties of Low-Substituted Hydroxypropylcellulose Low-substituted hydroxypropylcellulose was used as a commercial product, LH-21 (manufactured by Shin-Etsu Chemical Co., Ltd.). The average particle size, bulk density, and angle of repose of LH-21 were measured in the same manner as in Example 1, and the results are shown in Table 1.

【0036】実施例1と同様に、LH−21を圧縮成形
し膨潤率を測定した。その結果を図1に示す。
As in Example 1, LH-21 was compression molded and the swelling ratio was measured. The result is shown in FIG.

【0037】直接打錠による製錠 低置換度ヒドロキシプロピルセルロースがLH−21で
あることを除いて、実施例1と同様に、直接打錠用組成
物を調製し直接打錠を行なった。錠剤の重量偏差、硬
度、崩壊時間を表1に示す。
Tableting by Direct Compression A composition for direct compression was prepared and directly tableted in the same manner as in Example 1 except that the low-substituted hydroxypropylcellulose was LH-21. Table 1 shows the weight deviation, hardness, and disintegration time of the tablet.

【0038】流動層造粒 低置換度ヒドロキシプロピルセルロースがLH−21で
あることを除いて、実施例1と同様に、流動層造粒およ
び造粒末の打錠を行なった。重量200gの造粒末の平
均粒子径、かさ密度および錠剤の硬度、崩壊時間を表1
に示す。
Fluid bed granulation Fluid bed granulation and tableting of the granulated powder were carried out in the same manner as in Example 1 except that the low-substituted hydroxypropylcellulose was LH-21. Table 1 shows the average particle size, bulk density, tablet hardness and disintegration time of the granulated powder having a weight of 200 g.
Shown in

【0039】回転数30rpm、打錠圧1トンで重量が
200mgの錠剤を打錠した後、回転数のみを45rp
m、50rpmと変化させ、各回転数で打錠した錠剤の
重量を測定し、その結果を表2に示した。
After tableting a tablet weighing 200 mg at a rotation speed of 30 rpm and a tableting pressure of 1 ton, only the rotation speed was increased to 45 rpm.
m and 50 rpm, the weight of the tablets compressed at each rotation speed was measured, and the results are shown in Table 2.

【0040】比較例3 低置換度ヒドロキシプロピルセルロースの物性 低置換度ヒドロキシプロピルセルロースを市販品である
LH−31(信越化学工業製)とした。低置換度ヒドロ
キシプロピルセルロースに市販品であるLH−31(信
越化学工業製)を使用した。実施例1と同様にLH−3
1の平均粒子径、かさ密度および安息角を測定し、その
結果を表1に示した。
Comparative Example 3 Physical Properties of Low-Substituted Hydroxypropylcellulose The low-substituted hydroxypropylcellulose was used as a commercial product, LH-31 (manufactured by Shin-Etsu Chemical Co., Ltd.). Commercially available LH-31 (manufactured by Shin-Etsu Chemical Co., Ltd.) was used for the low-substituted hydroxypropylcellulose. LH-3 in the same manner as in Example 1.
The average particle size, bulk density, and angle of repose of Sample No. 1 were measured, and the results are shown in Table 1.

【0041】実施例1と同様に、LH−31を圧縮成形
し膨潤率を測定した。その結果を図1に示す。
As in Example 1, LH-31 was compression molded and the swelling ratio was measured. The result is shown in FIG.

【0042】直接打錠による製錠 低置換度ヒドロキシプロピルセルロースがLH−31で
あることを除いて、実施例1と同様に、直接打錠用組成
物を調製して直接打錠を行なった。錠剤の重量偏差、硬
度、崩壊時間を測定しその結果を表1に示す。
Tableting by Direct Compression A composition for direct compression was prepared and directly tableted in the same manner as in Example 1 except that the low-substituted hydroxypropylcellulose was LH-31. The weight deviation, hardness and disintegration time of the tablets were measured, and the results are shown in Table 1.

【0043】流動層造粒 低置換度ヒドロキシプロピルセルロースがLH−31で
あることを除いて、実施例1と同様に、流動層造粒およ
び造粒末の打錠を行なった。重量200gの造粒末の平
均粒子径、かさ密度および錠剤の硬度、崩壊時間を表1
に示す。
Fluid bed granulation Fluid bed granulation and tableting of the granulated powder were carried out in the same manner as in Example 1 except that the low-substituted hydroxypropylcellulose was LH-31. Table 1 shows the average particle size, bulk density, tablet hardness and disintegration time of the granulated powder having a weight of 200 g.
Shown in

【0044】実施例1と同様に、直接打錠および流動層
造粒を行なった。直接打錠により製錠された錠剤の物性
と、流動層造粒による造粒末の平均粒子径、かさ密度お
よび錠剤の硬度、崩壊時間とを測定しその結果を表1に
示す。
As in Example 1, direct compression and fluidized-bed granulation were performed. The physical properties of the tablets produced by direct compression, and the average particle size, bulk density, tablet hardness and disintegration time of the granulated powder obtained by fluidized bed granulation were measured, and the results are shown in Table 1.

【0045】回転数30rpm、打錠圧1トンで重量が
200mgの錠剤を打錠した後、回転数のみを45rp
m、50rpmと変化させ、各回転数で打錠した錠剤の
重量を測定し、その結果を表2に示した。
After tableting a tablet weighing 200 mg at a rotational speed of 30 rpm and a tableting pressure of 1 ton, only the rotational speed was increased to 45 rpm.
m and 50 rpm, the weight of the tablets compressed at each rotation speed was measured, and the results are shown in Table 2.

【0046】[0046]

【表1】 [Table 1]

【0047】[0047]

【表2】 [Table 2]

【0048】直接打錠法で打錠された実施例1、2の錠
剤は、比較例1〜3の錠剤と比べて重量偏差が小さく、
硬度が高い。また崩壊性にも優れている。これは図1に
見られるように、実施例1、2の低置換度ヒドロキシプ
ロピルセルロースである試料No.1およびNo.2の
膨潤率が100%以上だからである。
The tablets of Examples 1 and 2 compressed by the direct compression method had smaller weight deviations than the tablets of Comparative Examples 1 to 3,
High hardness. It also has excellent disintegration properties. As can be seen in FIG. 1, this is the low-substituted hydroxypropylcellulose of Examples 1 and 2, sample No. 1 and No. This is because the swelling ratio of No. 2 is 100% or more.

【0049】流動層造粒による実施例1、2の造粒末
は、比較例1〜3の造粒末と比べてかさ密度が高い。ま
た流動層造粒による実施例1、2の錠剤は、比較例1〜
3の錠剤と比べて硬度が高く崩壊性にも優れている。こ
れは実施例1、2の試料No.1およびNo.2の安息
角が45°未満のためである。回転数を大きくすると実
施例1、2の重量は安定しているが、比較例1〜3の重
量は低下してしまう。これは実施例1、2はかさ密度が
高いため充填量が一定に保たれるためである。
The granulated powders of Examples 1 and 2 obtained by fluidized bed granulation have a higher bulk density than the granulated powders of Comparative Examples 1 to 3. In addition, the tablets of Examples 1 and 2 obtained by fluidized bed granulation
The hardness is higher and the disintegration is superior to the tablet of No. 3. This corresponds to the sample Nos. 1 and No. This is because the angle of repose of No. 2 is less than 45 °. When the number of rotations is increased, the weights of Examples 1 and 2 are stable, but the weights of Comparative Examples 1 to 3 are reduced. This is because in Examples 1 and 2, the filling amount is kept constant because of the high bulk density.

【図面の簡単な説明】[Brief description of the drawings]

【図1】低置換度ヒドロキシプロピルセルロースの膨潤
率の経時変化を示す図である。
FIG. 1 is a graph showing the change over time in the swelling ratio of low-substituted hydroxypropylcellulose.

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 安息角が45°未満であり、活性アルミ
ナ80重量部に対して20重量部が配合され、成形圧1
トンで直径15mmの円板に成形されたものが水を吸収
して膨潤する際の体積増加率が100%以上であること
を特徴とする錠剤結合用の低置換度ヒドロキシプロピル
セルロース。
1. An angle of repose of less than 45 °, 20 parts by weight of 80 parts by weight of activated alumina, and a molding pressure of 1 part.
A low-substituted hydroxypropylcellulose for tablet binding, characterized in that a volume formed when a disc having a diameter of 15 mm is swollen by absorbing water is 100% or more.
【請求項2】 安息角が45°未満であり、活性アルミ
ナ80重量部に対して20重量部が配合され、成形圧1
トンで直径15mmの円板に成形されたものが水を吸収
して膨潤する際の体積増加率が100%以上である低置
換度ヒドロキシプロピルセルロースを成分に含むことを
特徴とする低置換度ヒドロキシプロピルセルロース組成
物。
2. An angle of repose of less than 45 °, 20 parts by weight of 80 parts by weight of activated alumina, and a molding pressure of 1 part.
Low-substituted hydroxypropyl cellulose having a low-substituted hydroxypropylcellulose having a volume increase rate of 100% or more when absorbing water and swelling into a disk having a diameter of 15 mm in tons. Propyl cellulose composition.
【請求項3】 安息角が45°未満であり、活性アルミ
ナ80重量部に対して20重量部が配合され、成形圧1
トンで直径15mmの円板に成形されたものが水を吸収
して膨潤する際の体積増加率が100%以上である低置
換度ヒドロキシプロピルセルロースで結合されているこ
とを特徴とする錠剤。
3. An angle of repose of less than 45 °, 20 parts by weight of 80 parts by weight of activated alumina, and a molding pressure of 1 part.
A tablet characterized by being bonded to a low-substituted hydroxypropylcellulose, which is formed into a disk having a diameter of 15 mm by ton and having a volume increase of 100% or more when absorbing water and swelling.
JP6117854A 1994-05-31 1994-05-31 Low-substituted hydroxypropylcellulose, composition thereof and tablet thereof Expired - Lifetime JP2994956B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6117854A JP2994956B2 (en) 1994-05-31 1994-05-31 Low-substituted hydroxypropylcellulose, composition thereof and tablet thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6117854A JP2994956B2 (en) 1994-05-31 1994-05-31 Low-substituted hydroxypropylcellulose, composition thereof and tablet thereof

Publications (2)

Publication Number Publication Date
JPH07324101A JPH07324101A (en) 1995-12-12
JP2994956B2 true JP2994956B2 (en) 1999-12-27

Family

ID=14721940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6117854A Expired - Lifetime JP2994956B2 (en) 1994-05-31 1994-05-31 Low-substituted hydroxypropylcellulose, composition thereof and tablet thereof

Country Status (1)

Country Link
JP (1) JP2994956B2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0890359B1 (en) * 1996-02-29 2002-05-02 Fujisawa Pharmaceutical Co., Ltd. Tablets containing beta-lactam antibiotic and process for producing the same
JP2000034224A (en) * 1998-05-11 2000-02-02 Freunt Ind Co Ltd Sustained-release tablet, additive composition for the tablet, and their production
JP3718341B2 (en) * 1998-05-12 2005-11-24 信越化学工業株式会社 Low substituted hydroxypropylcellulose and process for producing the same
JP4044689B2 (en) * 1998-12-07 2008-02-06 信越化学工業株式会社 Method for producing low substituted hydroxypropylcellulose
JP2000302802A (en) * 1999-04-21 2000-10-31 Shin Etsu Chem Co Ltd Method of forming hydroxypropyl cellulose particle with low degree of substitution
EP1054019A1 (en) * 1999-05-18 2000-11-22 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose
US6264983B1 (en) * 1999-09-16 2001-07-24 Rhodia, Inc. Directly compressible, ultra fine acetaminophen compositions and process for producing same
US6680069B1 (en) * 1999-11-09 2004-01-20 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose and process for manufacturing the same
JP3552160B2 (en) 2000-01-14 2004-08-11 信越化学工業株式会社 Method for forming low-substituted hydroxypropylcellulose particles
AU2001296000A1 (en) * 2000-10-24 2002-05-27 Ajinomoto Co., Inc. Nateglinide-containing hydrophilic drug preparations
EP1319670B1 (en) 2001-12-11 2007-07-25 Shin-Etsu Chemical Co., Ltd. Low-substituted hydroxypropyl cellulose
JP2003252749A (en) * 2002-03-04 2003-09-10 Shin Etsu Chem Co Ltd Base for external use
KR100525252B1 (en) 2003-12-16 2005-10-31 삼성정밀화학 주식회사 Method for preparation of fine powdered Cellulose ethers
US8343548B2 (en) 2006-08-08 2013-01-01 Shin-Etsu Chemical Co., Ltd. Solid dosage form comprising solid dispersion
JP5089287B2 (en) * 2006-08-08 2012-12-05 信越化学工業株式会社 Method for producing low substituted hydroxypropylcellulose powder
JP5258223B2 (en) * 2006-08-08 2013-08-07 信越化学工業株式会社 Solid preparation of enteric solid dispersion and method for producing the same
US8343547B2 (en) * 2006-08-08 2013-01-01 Shin-Etsu Chemical Co., Ltd. Solid dosage form comprising solid dispersion
JP5258224B2 (en) * 2006-08-08 2013-08-07 信越化学工業株式会社 Solid formulation of solid dispersion and method for producing the same
US8519120B2 (en) * 2006-08-08 2013-08-27 Shin-Etsu Chemical Co., Ltd. Methods for producing a low-substituted hydroxypropylcellulose powder
JP6077555B2 (en) * 2012-02-15 2017-02-08 武田薬品工業株式会社 tablet
JP7234076B2 (en) 2019-08-27 2023-03-07 信越化学工業株式会社 Method for producing sieved low-substituted hydroxypropyl cellulose

Also Published As

Publication number Publication date
JPH07324101A (en) 1995-12-12

Similar Documents

Publication Publication Date Title
JP2994956B2 (en) Low-substituted hydroxypropylcellulose, composition thereof and tablet thereof
JP5513564B2 (en) Low substituted hydroxypropylcellulose powder and solid preparation
US4091205A (en) Method for preparing low-substituted cellulose ethers
US20080102117A1 (en) Base material for dry direct tableting comprising low-substituted hydroxypropyl cellulose
JPH11322802A (en) Hydroxypropylcellulose having low substitution degree and its production
JP3212534B2 (en) Low substituted hydroxypropylcellulose powder
JP2008133432A (en) Low-substituted hydroxypropylcellulose powder and method for producing the same
EP1099709B1 (en) Low-substituted hydroxypropyl cellulose and process for manufacturing the same
JPS6121526B2 (en)
JPH0538732B2 (en)
KR20010029722A (en) Low Substituted Hydroxypropylcellulose
JP2017082211A (en) Pore water-soluble nonionic cellulose ether excellent in solubility and method of producing the same
JP4070402B2 (en) Low substituted hydroxypropylcellulose and process for producing the same
JP3850189B2 (en) Solid preparation and production method thereof
JP3408398B2 (en) Method for producing low substituted hydroxypropylcellulose powder
US7009046B2 (en) Low-substituted hydroxypropyl cellulose and agent serving both as binder and disintegrant for dry direct compression
JP4774739B2 (en) Kampo extract-containing tablet composition and method for producing the same
JP4290417B2 (en) Low substituted hydroxypropyl cellulose and dry direct hitting binder and disintegrant
CN103006614B (en) Cefuroxime axetil capsule in non-gel state in water and preparation method of cefuroxime axetil capsule
JP2518854B2 (en) Manufacturing method of solid formulation
JP2001347153A (en) Method for preparing tablet
WO2013182609A1 (en) Stable pharmaceutical compositions with a fast onset
JP2000239186A (en) Disintegrator for tablet

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081022

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091022

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091022

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101022

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101022

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111022

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121022

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131022

Year of fee payment: 14

EXPY Cancellation because of completion of term